1. Home
  2. CRAI vs PHAR Comparison

CRAI vs PHAR Comparison

Compare CRAI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

HOLD

Current Price

$149.08

Market Cap

898.0M

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.28

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRAI
PHAR
Founded
1965
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
898.0M
885.7M
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
CRAI
PHAR
Price
$149.08
$12.28
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$245.00
$38.33
AVG Volume (30 Days)
118.2K
9.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
1.48%
N/A
EPS Growth
20.77
N/A
EPS
8.14
N/A
Revenue
$751,583,000.00
N/A
Revenue This Year
$7.82
$10.04
Revenue Next Year
$5.14
$2.51
P/E Ratio
$18.24
$3,041.22
Revenue Growth
9.33
N/A
52 Week Low
$132.17
$9.54
52 Week High
$227.29
$21.34

Technical Indicators

Market Signals
Indicator
CRAI
PHAR
Relative Strength Index (RSI) 51.19 38.59
Support Level $142.53 $11.84
Resistance Level $166.99 $13.61
Average True Range (ATR) 5.87 0.46
MACD 0.93 0.09
Stochastic Oscillator 81.65 29.45

Price Performance

Historical Comparison
CRAI
PHAR

About CRAI CRA International Inc.

CRA International Inc is a consulting firm specializing in providing economic, financial and management consulting services. The company provides advisory services on economic and financial matters related to litigation and regulatory proceedings, and advises corporations on business and performance-related matters. Its consulting services are organized into two areas: litigation, regulatory and financial consulting, and management consulting. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. It derives revenues by providing professional and consulting services. Geographically, the maximum revenue is derived from the United States, followed by United Kingdom and other regions.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: